Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sirolimus and secondary skin-cancer prevention in kidney transplantation.
Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group. Euvrard S, et al. Among authors: chatelet v. N Engl J Med. 2012 Jul 26;367(4):329-39. doi: 10.1056/NEJMoa1204166. N Engl J Med. 2012. PMID: 22830463 Free article. Clinical Trial.
Women's Access to Kidney Transplantation in France: A Mixed Methods Research Protocol.
Adoli L, Raffray M, Châtelet V, Vigneau C, Lobbedez T, Gao F, Bayer F, Campéon A, Vabret E, Laude L, Jais JP, Daugas E, Couchoud C, Bayat S. Adoli L, et al. Among authors: chatelet v. Int J Environ Res Public Health. 2022 Oct 19;19(20):13524. doi: 10.3390/ijerph192013524. Int J Environ Res Public Health. 2022. PMID: 36294104 Free PMC article.
One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.
Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y. Sautenet B, et al. Among authors: chatelet v. Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958. Transplantation. 2016. PMID: 26555944 Clinical Trial.
Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.
Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D. Bertrand D, et al. Among authors: chatelet v. Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923. Transpl Int. 2017. PMID: 28120425 Free article.
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.
Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, Del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra A, Hofbauer GFL, Kamar N, Pouteil-Noble C, Kanitakis J, Roux A, Decullier E, Euvrard S; TUMORAPA Study Group. Dantal J, et al. Among authors: chatelet v. J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17. J Clin Oncol. 2018. PMID: 30016177 Clinical Trial.
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.
Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V. Zuber J, et al. Among authors: chatelet v. J Am Soc Nephrol. 2019 Dec;30(12):2449-2463. doi: 10.1681/ASN.2019040331. Epub 2019 Oct 1. J Am Soc Nephrol. 2019. PMID: 31575699 Free PMC article.
An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantation.
Bailly E, Ville S, Blancho G, Morelon E, Bamoulid J, Caillard S, Chatelet V, Malvezzi P, Tourret J, Vuiblet V, Anglicheau D, Bertrand D, Grimbert P, Haidar F, Hazzan M, Kamar N, Merville P, Mousson C, Pernin V, Pouteil-Noble C, Purgus R, Sayegh J, Westeel PF, Sautenet B, Gatault P, Büchler M. Bailly E, et al. Among authors: chatelet v. Transpl Int. 2020 Jul;33(7):786-795. doi: 10.1111/tri.13613. Epub 2020 May 5. Transpl Int. 2020. PMID: 32279367 Free article. Clinical Trial.
Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study.
Barba T, Bachy E, Maarek A, Fossard G, Genestier L, Anglicheau D, Moal V, Dantal J, Rieu P, Chemouny J, Charrier M, Durrbach A, Provot F, Ducloux D, Westeel PF, Heng AE, Rerolle JP, Barrou B, Grimbert P, Chatelet V, Mousson C, Janbon B, Pernin V, Frimat L, Ouali N, Glotz D, Thierry A, Mariat C, Büchler M, Gaulard P, Leblond V, Morelon E, Dubois V, Salles G, Caillard S, Thaunat O. Barba T, et al. Among authors: chatelet v. Transplantation. 2021 Aug 1;105(8):1858-1868. doi: 10.1097/TP.0000000000003568. Transplantation. 2021. PMID: 33560724
[BK virus infections in kidney transplantation].
Lanot A, Bouvier N, Chatelet V, Dina J, Béchade C, Ficheux M, Henri P, Lobbedez T, Hurault de Ligny B. Lanot A, et al. Among authors: chatelet v. Nephrol Ther. 2016 Apr;12(2):76-85. doi: 10.1016/j.nephro.2015.11.003. Epub 2016 Jan 28. Nephrol Ther. 2016. PMID: 26827190 French.
67 results